Article By:
The Daily Marijuana Observer
Tuesday, September 19, 2017 9:37 PM EDT
Since the last time we covered RespireRx, shares have fallen notably. The company's drug pipeline and recent developments show us that the decline in share price is an opportunity if anything.
